表纸
市场调查报告书

感染疾病诊断的全球市场 (~2027年):消耗品、系统软体、服务

Infectious Disease Diagnostics Market by Product & Solution (Consumables, System, Software & Services), Technology (Immunodiagnostics, PCR, INAAT), Disease (HIV, HAIS, Influenza), End User (Hospital, Reference Lab, Research)-Global Forecast to 2027

出版商 Meticulous Market Research Pvt. Ltd. 商品编码 946874
出版日期 内容资讯 英文 200 Pages
订单完成后即时交付
价格
感染疾病诊断的全球市场 (~2027年):消耗品、系统软体、服务 Infectious Disease Diagnostics Market by Product & Solution (Consumables, System, Software & Services), Technology (Immunodiagnostics, PCR, INAAT), Disease (HIV, HAIS, Influenza), End User (Hospital, Reference Lab, Research)-Global Forecast to 2027
出版日期: 2020年07月03日内容资讯: 英文 200 Pages
简介

全球感染疾病诊断的市场在预测期间内预计以7.4%的年复合成长率发展,2027年成长到231亿7000万美元的规模。各技术中,估计免疫诊断的部门在2020年中占最大的占有率。传染病检查的免疫化验利用的增加,新检验的开发,自动化的扩大,健康和健身的意识扩大,设备相关的并发症的减轻等要素促进该部门成长。

本报告提供全球感染疾病诊断的市场调查,市场及技术概要,市场成长的各种影响因素分析,市场规模的变化、预测,产品、服务、技术、疾病区分、终端用户、地区/主要国家等各种区分的明细,竞争环境,主要企业简介等汇整。

第1章 简介

第2章 调查手法

第3章 摘要整理

第4章 市场分析

  • 简介
  • 促进因素
  • 阻碍因素
  • 市场机会
  • 课题

第5章 市场分析、预测:各产品、服务

  • 简介
  • 消耗品
  • 设备
  • 软体、服务

第6章 市场分析、预测:各技术

  • 简介
  • 免疫诊断
  • 临床微生物检验
  • 聚合酵素链锁反应(PCR)
  • 恒温核酸增幅技术(INAAT)
  • DNA序列、下一代序列(NGS)
  • DNA微阵列
  • 其他

第7章 市场分析、预测:各疾病

  • 简介
  • 肝炎
  • 人免疫力缺乏病毒(HIV)
  • 院内感染(HAI)
  • 人类乳突病毒(HPV)
  • 结核(TB)
  • 流感
  • 其他

第8章 市场分析、预测:各终端用户

  • 简介
  • 医院、临床实验室
  • 诊断 索引实验室
  • 学术、研究机关
  • 其他

第9章 市场分析、预测:各地区、主要国家

  • 简介
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他
  • 南美
  • 中东、非洲

第10章 竞争情形

  • 简介
  • 主要成长策略
  • 企业占有率分析

第11章 企业简介

  • Abbott Laboratories
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Biomerieux SA
  • F. Hoffmann-La Roche, Ltd.
  • Becton, Dickinson and Company
  • Diasorin s.p.a.
  • Meridian Bioscience,Inc.
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.

第12章 附录

目录

Title:
Infectious Disease Diagnostics Market
by Product & Solution (Consumables, System, Software & Services), Technology (Immunodiagnostics, PCR, INAAT), Disease (HIV, HAIS, Influenza), End User (Hospital, Reference Lab, Research) - Forecast to 2027.

The infectious disease diagnostics market is expected to grow at a CAGR of 7.4% from 2020 to 2027 to reach $23.17 billion by 2027.

Succeeding an extensive secondary and primary research and in-depth analysis of the market scenario, the report carries out the in-depth analysis on key industry drivers, restraints, challenges, and opportunities. The growth in the infectious disease diagnostics market is mainly attributed to the increasing global prevalence of infectious diseases such as COVID-19, Ebola, and Swine Flu, among others; growing awareness for early detection using specific diagnostic tests; growth in funding for research on infectious disease diagnostics; and shift in focus from centralized laboratories to decentralized point-of-care testing services. Moreover, advances in genomics and proteomics and emerging countries provide increasing growth opportunities for players operating in the infectious disease diagnostics market.

The infectious disease diagnostics market study presents historical market data in terms of value (2018, and 2019), estimated current data (2020), and forecasts for 2027 - by product & solution, technology, disease type, and end user. The study also evaluates industry competitors and analyzes the market at regional and country level.

Based on products & solutions, the consumables segment is estimated to hold the largest share of the overall infectious disease diagnostics market in 2020. The large share of this segment is mainly attributed to the increasing prevalence of infectious diseases, rising awareness among the population to identify the diseases, and increasing use of kits and reagents to identify the organism causing various diseases in lesser time and cost.

On the basis of technology, the immunodiagnostics segment is estimated to account for the largest share of the overall infectious disease diagnostics market in 2020. Increasing use of immunoassays in infectious disease testing, development of novel tests, rising trend of automation, increasing awareness about the health and fitness, and reduced complications associated with the instruments are some of the major factors driving the growth of this market.

On the basis of disease type, the hepatitis diseases segment is estimated to hold the largest share of the overall infectious disease diagnostics market in 2020. Increasing number of blood transfusions and donations, increasing prevalence of hepatitis B & C infections, rising susceptibility of the geriatric population, growing awareness among the population, and benefits offered by point of care instruments & kits are expected to propel the growth of this segment.

An in-depth analysis of the geographical scenario of the infectious disease diagnostics market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America region is estimated to command the largest share of the global infectious disease diagnostics market in 2020, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. However, Asia Pacific region is slated to register the highest growth during the forecast period primarily due to the rapid urbanization, increasing investments by healthcare providers towards infrastructure improvement, need to manage growing burden of infectious diseases, and government efforts to improve the accessibility of diagnostic services to enhance the prevention by developing products or platforms required for the diagnosis of infectious diseases.

The key players operating in the global infectious disease diagnostics market are Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioMerieux S.A. (France), Thermo Fisher Scientific (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company (U.S.), DiaSorin S.p.A. (Italy), Meridian Bioscience Inc. (U.S.), and Quidel Corporation (U.S.) among others.

Scope of the Report:

Market, by Product & Solutions

  • Consumables
  • Instruments
  • Software & Services

Market, by Technology

  • Immunodiagnostics
  • Clinical Microbiology
  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification Technology
  • DNA Sequencing and Next-Generation Sequencing (NGS)
  • DNA Microarray Technology
  • Other technologies

Other Technologies comprises of microscopy, hybridization, and loop-mediated isothermal amplification

Market, by Disease Type

  • Hepatitis
  • Human Immunodeficiency Virus (HIV)
  • Hospital-Acquired Infections (HAIS)
  • Human Papillomavirus (HPV)
  • Tuberculosis (TB)
  • Influenza
  • Other Diseases

Other diseases comprise of measles, small pox, mumps, typhoid fever, malaria, meningitis, Ebola virus disease, Lyme disease, coronavirus disease, and whooping cough.

Market, by End Users

  • Hospital/Clinical Laboratories
  • Reference Laboratories
  • Academics/Research Institutes
  • Other End Users

Other end users comprise of physician offices, nursing facilities, and home healthcare agencies

Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
  • Japan
  • China
  • India
  • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Table of Contents

"1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-Up Approach
      • 2.3.1.2. Top-Down Approach
      • 2.3.1.3. Growth Forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for The Study
  • 2.5. Limitations for The Study

3. Executive Summary

4. Market Insights

  • 4.1. Introduction
  • 4.2. Drivers
    • 4.2.1. Increasing Prevalence of Infectious Diseases
    • 4.2.2. Growing Awareness of Early Disease Diagnosis
    • 4.2.3. Impact of COVID-19
    • 4.2.4. Rising Funds for Infectious Disease Diagnostics Research Activities
    • 4.2.5. Shift in Focus from Centralized Laboratories to POC Testing Services
  • 4.3. Restraints
    • 4.3.1. Unfavorable and Inadequate Reimbursement Scenario
  • 4.4. Opportunities
    • 4.4.1. Advances in Genomics and Proteomics
    • 4.4.2. Growing Awareness About Personalized Medicine
    • 4.4.3. Emerging Economies
  • 4.5. Challenges
    • 4.5.1. Lack of Awareness of Specific Symptoms and Diagnosis of Emerging Infections

5. Global Infectious Disease Diagnostics Market, by Product & Service

  • 5.1. Introduction
  • 5.2. Consumables
  • 5.3. Instruments
  • 5.4. Software & Services

6. Global Infectious Disease Diagnostics Market, by Technology

  • 6.1. Introduction
  • 6.2. Immunodiagnostics
  • 6.3. Clinical Microbiology
  • 6.4. Polymerase Chain Reaction (PCR)
  • 6.5. Isothermal Nucleic Acid Amplification Technology (INAAT)
  • 6.6. DNA Sequencing and Next-Generation Sequencing (NGS)
  • 6.7. DNA Microarray
  • 6.8. Other Technologies

7. Global Infectious Disease Diagnostics Market, by Disease Type

  • 7.1. Introduction
  • 7.2. Hepatitis
  • 7.3. Human Immunodeficiency Virus (HIV)
  • 7.4. Hospital-Acquired Infections (HAIs)
  • 7.5. Human Papillomavirus (HPV)
  • 7.6. Tuberculosis (TB)
  • 7.7. Influenza
  • 7.8. Other Infectious Diseases

8. Global Infectious Disease Diagnostics Market, by End User

  • 8.1. Introduction
  • 8.2. Hospital & Clinical Laboratories
  • 8.3. Diagnostic Reference Laboratories
  • 8.4. Academic & Research Institutes
  • 8.5. Other End Users

9. Global Infectious Disease Diagnostics Market, by Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe (RoE)
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific (RoAPAC)
  • 9.5. Latin America
  • 9.6. Middle East and Africa

10. Competitive Landscape

  • 10.1. Introduction
  • 10.2. Key Growth Strategies
  • 10.3. Market Share Analysis (2019)
    • 10.3.1. F. Hoffmann-La Roche Ltd.
    • 10.3.2. Abbott Laboratories
    • 10.3.3. Danaher Corporation

11. Company Profiles

  • 11.1. Abbott Laboratories
    • 11.1.1. Business Overview
    • 11.1.2. Financial Overview
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Development
      • 11.1.4.1. New Product Launches and Approvals
      • 11.1.4.2. Acquisitions
      • 11.1.4.3. Partnerships
  • 11.2. Danaher Corporation
    • 11.2.1. Business Overview
    • 11.2.2. Financial Overview
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Developments
      • 11.2.4.1. New Product/Service Launches and Approvals
      • 11.2.4.2. Acquisitions
      • 11.2.4.3. Partnerships, Collaborations, and Agreements
  • 11.3. Bio-Rad Laboratories, Inc.
    • 11.3.1. Business Overview
    • 11.3.2. Financial Overview
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Developments
      • 11.3.4.1. New Product Launches and Approvals
  • 11.4. Biomerieux S.A.
    • 11.4.1. Business Overview
    • 11.4.2. Financial Overview
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Development
      • 11.4.4.1. New Product Launches & Approvals
      • 11.4.4.2. Acquisitions
  • 11.5. F. Hoffmann-La Roche, Ltd.
    • 11.5.1. Business Overview
    • 11.5.2. Financial Overview
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Development
      • 11.5.4.1. New Product Launches & Approvals
  • 11.6. Becton, Dickinson and Company
    • 11.6.1. Business Overview
    • 11.6.2. Financial Overview
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Developments
      • 11.6.4.1. New Product Launches, Enhancements, and Approvals
      • 11.6.4.2. Acquisitions
      • 11.6.4.2. Agreements
  • 11.7. Diasorin s.p.a.
    • 11.7.1. Business Overview
    • 11.7.2. Financial Overview
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Developments
      • 11.7.4.1. New Product Launches & Approvals
      • 11.7.4.2. Acquisitions
      • 11.7.4.3. Collaborations
  • 11.8. Meridian Bioscience, Inc.
    • 11.8.1. Business Overview
    • 11.8.2. Financial Overview
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Developments
      • 11.8.4.1. New Product Launches and Enhancements
      • 11.8.4.2. Collaborations
      • 11.8.4.3. Acquisitions
  • 11.9. Quidel Corporation
    • 11.9.1. Business Overview
    • 11.9.2. Financial Overview
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Developments
      • 11.9.4.1. Product Approvals
      • 11.9.4.2. Acquisitions
  • 11.10. Thermo Fisher Scientific, Inc.
    • 11.10.1. Business Overview
    • 11.10.2. Financial Overview
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Developments
      • 11.10.4.1. New Product Launches and Approvals
      • 11.10.4.2. Collaborations
      • 11.10.4.3. Acquisitions

12. Appendix

  • 12.1. Questionnaire
  • 12.2. Available Customization

List of Tables

  • Table 1 Global Infectious Disease Diagnostics Market Drivers: Impact Analysis (2020-2027)
  • Table 2 COVID 19 Confirmed Cases and Deaths Across the World (2nd May 2020)
  • Table 3 Recent Diagnostic Tests Launched for COVID-19
  • Table 4 Global Infectious Disease Diagnostics Market Restraints: Impact Analysis (2020-2027)
  • Table 5 Clinical Applications of Infectious Disease Genomics and Proteomics
  • Table 6 Global Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 7 Recent Launches and Approvals in The Consumables Market
  • Table 8 Key Companies Offering Infectious Disease Diagnostic Consumables
  • Table 9 Global Infectious Disease Diagnostic Consumables Market Size, by Country/Region, 2018-2027 ($ Million)
  • Table 10 Key Companies Offering Infectious Disease Diagnostic Instruments
  • Table 11 Global Infectious Disease Diagnostic Instruments Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 12 Key Companies Offering Infectious Disease Diagnostic Software and Services
  • Table 13 Global Infectious Disease Diagnostic Software & Services Market Size, by Country/Region, 2018-2027 ($ Million)
  • Table 14 Global Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($ Million)
  • Table 15 Key Companies Offering Immunodiagnostic-Based Products
  • Table 16 Global Immunodiagnostic-Based Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($ Million)
  • Table 17 Global Clinical Microbiology-Based Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 18 Key Companies Offering PCR-Based Products
  • Table 19 Global PCR-Based Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 20 Global INAAT-Based Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($ Million)
  • Table 21 Global DNA Sequencing and NGS-Based Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 22 Global DNA Microarray-Based Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 23 Global Infectious Disease Diagnostics Market Size for Other Technologies, by Country/Region, 2018-2027 ($Million)
  • Table 24 Global Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 25 Global Infectious Disease Diagnostics Market Size for Hepatitis, by Country/Region, 2018-2027 ($ Million)
  • Table 26 Key Players Offering HIV Diagnostic Products
  • Table 27 Global Infectious Disease Diagnostics Market Size for HIV, by Country/Region, 2018-2027 ($Million)
  • Table 28 Global Infectious Disease Diagnostics Market Size for HAIs, by Country/Region, 2018-2027 ($ Million)
  • Table 29 Global Infectious Disease Diagnostics Market Size for HPV, by Country/Region, 2018-2027 ($ Million)
  • Table 30 Global Infectious Disease Diagnostics Market Size for Tuberculosis, by Country/Region, 2018-2027 ($ Million)
  • Table 31 Some of the FDA-Cleared Nucleic Acid Detection-Based Tests for Influenza (2019)
  • Table 32 Global Infectious Disease Diagnostics Market Size for Influenza, by Country, 2018-2027 ($ Million)
  • Table 33 COVID 19 Confirmed Cases and Deaths Across the World (2nd May 2020)
  • Table 34 Diagnostic Tests for COVID-19
  • Table 35 Global Infectious Disease Diagnostics Market Size for Other Infectious Diseases, by Country, 2018-2027 ($ Million)
  • Table 36 Global Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($ Million)
  • Table 37 Global Infectious Disease Diagnostics Market Size for Hospital & Clinical Laboratories, by Country, 2018-2027 ($ Million)
  • Table 38 Global Infectious Disease Diagnostics Market Size for Diagnostic Reference Laboratories, by Country, 2017-2027 ($Million)
  • Table 39 Global Infectious Disease Diagnostics Market Size for Academic & Research Institutes, by Country, 2017-2027 ($Million)
  • Table 40 Global Infectious Disease Diagnostics Market Size for Other End Users, by Country, 2017-2027 ($Million)
  • Table 41 Global Infectious Disease Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 42 North America: Infectious Disease Diagnostics Market Size, by Country, 2018-2027 ($Million)
  • Table 43 North America: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 44 North America: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 45 North America: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 46 North America: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 47 U.S.: Disease Rate and Number of New Cases (2016 & 2017)
  • Table 48 U.S.: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 49 U.S.: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 50 U.S.: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 51 U.S.: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 52 Canada: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 53 Canada: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 54 Canada: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 55 Canada: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 56 Europe: Infectious Disease Diagnostics Market Size, by Country, 2018-2027 ($Million)
  • Table 57 Europe: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 58 Europe: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 59 Europe: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 60 Europe: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 61 Germany: HIV and AIDS Estimates (2018)
  • Table 62 Personalized Therapies Authorized in Germany (2017)
  • Table 63 Germany: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 64 Germany: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 65 Germany: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 66 Germany: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 67 France: Percentage of Older People (65 Years and Above), 2010-2050
  • Table 68 France: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 69 France: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 70 France: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 71 France: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 72 U.K.: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 73 U.K.: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 74 U.K.: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 75 U.K.: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 76 Italy: Cancer Prevalence 2018
  • Table 77 Number of Cancer Cases, (2018 Vs 2040)
  • Table 78 Italy: Covid-19 Cases
  • Table 79 Italy: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 80 Italy: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 81 Italy: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 82 Italy: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 83 Spain: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 84 Spain: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 85 Spain: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 86 Spain: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 87 Hepatitis A Cases (2016 Vs.2017)
  • Table 88 Covid-19 Cases in European Countries
  • Table 89 RoE: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 90 RoE: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 91 RoE: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 92 RoE: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 93 Asia-Pacific: Infectious Disease Diagnostics Market Size, by Country, 2018-2027 ($Million)
  • Table 94 Asia-Pacific: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 95 Asia-Pacific: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 96 Asia-Pacific: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 97 Asia-Pacific: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 98 China: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 99 China: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 100 China: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 101 China: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 102 Japan: Percentage Geriatric Population (65 and Over)
  • Table 103 Japan: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 104 Japan: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 105 Japan: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 106 Japan: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 107 India: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 108 India: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 109 India: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 110 India: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 111 RoAPAC: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 112 RoAPAC: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 113 RoAPAC: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 114 RoAPAC: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 115 Latin America: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 116 Latin America: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 117 Latin America: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 118 Latin America: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 119 EDCTP Funding for Infectious Disease Diagnostics (2003-2018)
  • Table 120 Middle East & Africa: Infectious Disease Diagnostics Market Size, by Product & Service, 2018-2027 ($Million)
  • Table 121 Middle East & Africa: Infectious Disease Diagnostics Market Size, by Technology, 2018-2027 ($Million)
  • Table 122 Middle East & Africa: Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2027 ($Million)
  • Table 123 Middle East & Africa: Infectious Disease Diagnostics Market Size, by End User, 2018-2027 ($Million)

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global Infectious Disease Diagnostics Market, by Product & Service, 2020 Vs. 2027 ($Million)
  • Figure 8 Global Infectious Disease Diagnostics Market Size, by Technology, 2020 Vs. 2027 ($Million)
  • Figure 9 Global Infectious Disease Diagnostics Market Size, by Disease Type, 2020 Vs. 2027 ($Million)
  • Figure 10 Hospitals & Clinical Laboratories Are Expected to Dominate the Global Infectious Disease Diagnostics Market, by End User (2020-2027)
  • Figure 11 Infectious Disease Diagnostics Market, by Region
  • Figure 12 Market Dynamics
  • Figure 13 Global Infectious Disease Diagnostics Market Size, by Product & Service, 2020-2027 ($Million)
  • Figure 14 Global Infectious Disease Diagnostics Market Size, by Technology, 2020-2027 ($Million)
  • Figure 15 Global Infectious Disease Diagnostics Market Size, by Disease Type, 2020-2027 ($Million)
  • Figure 16 U.S.: Hospital-Acquired Infections
  • Figure 17 Tuberculosis R&D Funding (2015-2018)
  • Figure 18 Laboratory Confirmed Hospitalization Rate for Influenza, 2019-2020
  • Figure 19 Global Infectious Disease Diagnostics Market Size, by End User, 2020-2027 ($Million)
  • Figure 20 Tuberculosis R&D Funding (2015-2018)
  • Figure 21 Global Infectious Disease Diagnostics Market Size, by Geography, 2020-2027 ($Million)
  • Figure 22 North America: Infectious Disease Diagnostics Market Snapshot
  • Figure 23 U.S. Health Expenditure for Homecare Settings (2005-2017) (In $Billion)
  • Figure 24 Europe: Infectious Disease Diagnostics Market Snapshot
  • Figure 25 Germany: Infection Data, by Infection Site, 2010-2016 (%)
  • Figure 26 Asia-Pacific: Infectious Disease Diagnostics Market Snapshot
  • Figure 27 China: Geriatric Population (Million)
  • Figure 28 Coronavirus Outbreak in Latin America (6th May 2020)
  • Figure 29 Healthcare Expenditure in Latin America (2012-2016)
  • Figure 30 Key Growth Strategies Adopted by Leading Players, 2017-2020
  • Figure 31 Infectious Disease Diagnostics: Competitive Benchmarking
  • Figure 32 Market Share Analysis: Infectious Disease Diagnostics Industry, 2019
  • Figure 33 Abbott Laboratories: Financial Overview (2019)
  • Figure 34 Danaher Corporation: Financial Overview (2019)
  • Figure 35 Bio-Rad Laboratories, Inc.: Financial Overview (2019)
  • Figure 36 Biomerieux S.A.: Financial Overview (2018)
  • Figure 37 F. Hoffmann-La Roche, Ltd.: Financial Overview (2019)
  • Figure 38 Becton, Dickinson and Company: Financial Overview (2019)
  • Figure 39 Diasorin s.p.a.: Financial Overview (2018)
  • Figure 40 Meridian Bioscience, Inc.: Financial Overview (2019)
  • Figure 41 Quidel Corporation: Financial Overview (2019)
  • Figure 42 Thermo Fisher Scientific, Inc.: Financial Overview (2019)